Philippe Margaron

1.6k total citations · 1 hit paper
46 papers, 1.2k citations indexed

About

Philippe Margaron is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philippe Margaron has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Ophthalmology, 19 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philippe Margaron's work include Retinal Diseases and Treatments (27 papers), Retinal and Optic Conditions (17 papers) and Retinal Imaging and Analysis (17 papers). Philippe Margaron is often cited by papers focused on Retinal Diseases and Treatments (27 papers), Retinal and Optic Conditions (17 papers) and Retinal Imaging and Analysis (17 papers). Philippe Margaron collaborates with scholars based in Switzerland, Canada and United States. Philippe Margaron's co-authors include Johan E. van Lier, Timothy Y. Y. Lai, Colin S. Tan, Kanji Takahashi, Tock Han Lim, Won Ki Lee, David W. C. Hunt, Adrian Koh, Paisan Ruamviboonsuk and Lee-Jen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and Ophthalmology.

In The Last Decade

Philippe Margaron

45 papers receiving 1.2k citations

Hit Papers

Efficacy and Safety of Ranibizumab With or Without Vertep... 2017 2026 2020 2023 2017 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    2017 214 citations Timothy Y. Y. Lai, Kanji Takahashi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Margaron Switzerland 16 730 562 269 222 214 46 1.2k
Chia‐Yi Lee Taiwan 15 325 0.4× 229 0.4× 50 0.2× 193 0.9× 59 0.3× 150 871
Yuji Itoh Japan 19 789 1.1× 714 1.3× 18 0.1× 220 1.0× 35 0.2× 59 1.2k
Lin Xie China 14 168 0.2× 168 0.3× 15 0.1× 136 0.6× 28 0.1× 32 450
Amy P. Chiu Canada 13 55 0.1× 61 0.1× 12 0.0× 173 0.8× 57 0.3× 16 488
Amy Buckley Ireland 8 21 0.0× 42 0.1× 76 0.3× 265 1.2× 74 0.3× 16 533
Lata Singh India 12 203 0.3× 29 0.1× 39 0.1× 188 0.8× 15 0.1× 63 455
Linjing Li China 17 82 0.1× 35 0.1× 42 0.2× 493 2.2× 15 0.1× 36 636
Conghui Zhang China 14 85 0.1× 58 0.1× 20 0.1× 190 0.9× 11 0.1× 34 490
Paolo G. Montaldo Italy 14 32 0.0× 43 0.1× 39 0.1× 447 2.0× 33 0.2× 20 700

Countries citing papers authored by Philippe Margaron

Since Specialization
Citations

This map shows the geographic impact of Philippe Margaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Margaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Margaron more than expected).

Fields of papers citing papers by Philippe Margaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Margaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Margaron. The network helps show where Philippe Margaron may publish in the future.

Co-authorship network of co-authors of Philippe Margaron

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Margaron. A scholar is included among the top collaborators of Philippe Margaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Margaron. Philippe Margaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
London, Nikolas, Chui Ming Gemmy Cheung, Stephan Michels, et al.. (2025). Outcomes by Faricimab Treatment Interval at Week 48 of TENAYA-LUCERNE Phase III Trials in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 9(11). 1081–1089.
2.
Zarbin, Marco A., Christina Y. Weng, Nikolas London, et al.. (2024). Disease Activity Criteria Impact Dosing Interval Assignment in Neovascular Age-related Macular Degeneration Trials. Ophthalmology Retina. 9(4). 404–407. 2 indexed citations
3.
Chaudhary, Varun, Andrew Y. Chang, Antonia M. Joussen, et al.. (2024). Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Graefe s Archive for Clinical and Experimental Ophthalmology. 263(5). 1239–1247. 8 indexed citations
4.
5.
Cheung, Chui Ming Gemmy, Jennifer I. Lim, Siegfried Priglinger, et al.. (2024). Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration. Ophthalmology. 132(5). 519–526. 3 indexed citations
6.
Abreu, Francis, Caroline R. Baumal, Dolly S. Chang, et al.. (2024). Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(11). 3437–3451. 15 indexed citations
7.
Tan, Colin S., Louis W. Lim, & Philippe Margaron. (2021). Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy. SHILAP Revista de lepidopterología. 2(1). 100082–100082. 2 indexed citations
8.
Schmidt‐Erfurth, Ursula, Zufar Mulyukov, Bianca S. Gerendas, et al.. (2020). A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis. Investigative Ophthalmology & Visual Science. 61(7). 1159–1159. 3 indexed citations
9.
Bogunović, Hrvoje, John W. Seaman, Philippe Margaron, et al.. (2020). Detection of retinal fluids in OCT scans by an automated deep learning algorithm compared to human expert grading in the HAWK & HARRIER trials. Investigative Ophthalmology & Visual Science. 61(7). 5187–5187. 2 indexed citations
10.
11.
Lai, Timothy Y. Y., Chrystel Feller, Philippe Margaron, & Colin S. Tan. (2017). Anatomical outcomes of ranibizumab 0.5 mg combined with verteporfin photodynamic therapy vs ranibizumab monotherapy in patients with polypoidal choroidal vasculopathy: 12-month results from the EVEREST II study. Investigative Ophthalmology & Visual Science. 58(8). 408–408. 1 indexed citations
12.
Dugel, Pravin U., Jost Hillenkamp, Sobha Sivaprasad, et al.. (2016). Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials. Clinical ophthalmology. 10. 1103–1103. 51 indexed citations
13.
Wu, Tinghuai, Masashi Fujihara, Jane Tian, et al.. (2010). Apolipoprotein B100 secretion by cultured ARPE‐19 cells is modulated by alteration of cholesterol levels. Journal of Neurochemistry. 114(6). 1734–1744. 28 indexed citations
14.
Margaron, Philippe, et al.. (2009). Evaluation of Intravitreal cis-Retinoid Replacement Therapy in a Canine Model of Leber’s Congenital Amaurosis. Investigative Ophthalmology & Visual Science. 50(13). 6280–6280. 2 indexed citations
15.
Wu, Jun, et al.. (2006). Anti–Angiogenic and Anti–Inflammatory Effects of Statins on Endothelial and Retinal Pigment Epithelial Cells. Investigative Ophthalmology & Visual Science. 47(13). 1433–1433. 1 indexed citations
16.
Margaron, Philippe, et al.. (2006). In vitro Release Profiles of Atrigel® Sustained Release Formulations. Investigative Ophthalmology & Visual Science. 47(13). 5116–5116. 1 indexed citations
17.
Zhou, Shuai, et al.. (2005). Expression of Vascular Endothelial Growth Factor (VEGF) and Effects of Anti–VEGF Treatment in the Rat Chorioretina After Photodynamic Therapy With Verteporfin. Investigative Ophthalmology & Visual Science. 46(13). 343–343. 1 indexed citations
18.
Granville, David J., et al.. (1999). Release of Cytochrome c, Bax Migration, Bid Cleavage, and Activation of Caspases 2, 3, 6, 7, 8, and 9 during Endothelial Cell Apoptosis. American Journal Of Pathology. 155(4). 1021–1025. 86 indexed citations
19.
Margaron, Philippe, et al.. (1997). Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1359(3). 200–210. 32 indexed citations
20.
Margaron, Philippe, et al.. (1996). Structure‐Photodynamic Activity Relationships of a Series of 4‐Substituted Zinc Phthalocyanines. Photochemistry and Photobiology. 63(2). 217–223. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chia‐Yi Lee Breakdown of academic impact, for papers by Yuji Itoh Breakdown of academic impact, for papers by Lin Xie Breakdown of academic impact, for papers by Amy P. Chiu Breakdown of academic impact, for papers by Amy Buckley Breakdown of academic impact, for papers by Lata Singh Breakdown of academic impact, for papers by Linjing Li Breakdown of academic impact, for papers by Conghui Zhang Breakdown of academic impact, for papers by Paolo G. Montaldo
Rankless by CCL
2026